A prudent path forward for genomic engineering and germline gene modification
Top Cited Papers
- 3 April 2015
- journal article
- perspective
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 348 (6230) , 36-38
- https://doi.org/10.1126/science.aab1028
Abstract
Genome engineering technology offers unparalleled potential for modifying human and nonhuman genomes. In humans, it holds the promise of curing genetic disease, while in other organisms it provides methods to reshape the biosphere for the benefit of the environment and human societies. However, with such enormous opportunities come unknown risks to human health and well-being. In January, a group of interested stakeholders met in Napa, California (1), to discuss the scientific, medical, legal, and ethical implications of these new prospects for genome biology. The goal was to initiate an informed discussion of the uses of genome engineering technology, and to identify those areas where action is essential to prepare for future developments. The meeting identified immediate steps to take toward ensuring that the application of genome engineering technology is performed safely and ethically.Keywords
Funding Information
- Caribou Biosciences, Inc.
This publication has 7 references indexed in Scilit:
- The new frontier of genome engineering with CRISPR-Cas9Science, 2014
- The iCRISPR Platform for Rapid Genome Editing in Human Pluripotent Stem CellsPublished by Elsevier ,2014
- Genome editing with Cas9 in adult mice corrects a disease mutation and phenotypeNature Biotechnology, 2014
- Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell EmbryosCell, 2014
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome EngineeringCell, 2013
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Towards germline gene therapy of inherited mitochondrial diseasesNature, 2012